GSK plc (BCBA:GSK)

Market Cap	124.13T
Revenue (ttm)	51.64T
Net Income (ttm)	5.59T
Shares Out	n/a
EPS (ttm)	1,348.99
PE Ratio	22.21
Forward PE	9.31
Dividend	412.68 (2.60%)
Ex-Dividend Date	Aug 15, 2025

Volume	736
Average Volume	892
Open	17,140
Previous Close	16,740
Day's Range	16,080 - 17,140
52-Week Range	9,110 - 17,930
Beta	n/a
RSI	54.17
Earnings Date	Oct 29, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 68,629
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: GSK

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP